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Fractures are the most serious consequence of osteoporosis. Non-vertebral and non-hip fractures are 
seldom recognised as important, even though they account for the majority of all fractures. The most 
prevalent localisations are distal radius, proximal humerus, ribs, clavicle, and the pelvis. According to 
the results from large phase III clinical trials for placebo groups, their incidence ranges from 4.9 % to 
12.0 %. Hospital morbidity data in Croatia in 2006 show that peripheral non-hip fractures ranked among 
the leading fifteen injuries, accounting for 23.7 % of all injuries in patients aged 60 years and above. Risk 
factors for non-hip and non-vertebral fractures are similar to other osteoporotic fractures, and the main 
are low bone mineral density and earlier fractures. Quality of life is considerably affected by these fractures, 
and medical costs are very high, soaring as high as 36.9 % of all national medical costs in the USA. Non-
vertebral non-hip fractures need more attention, which was also recognised by the European regulatory 
bodies that approve use of anti-osteoporotic drugs.
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Osteoporosis is a metabolic bone disease and 
one of the most serious public health problems. It is 
estimated that around 43 million women in Europe 
have osteoporosis and that in the year 2000, women 
aged over 50 years had 2.8 million fractures (1). The 
lifetime risk for any osteoporotic fracture in 50-year-
old women is 46 % in Sweden and 53 % in Great 
Britain (2).
Main attention in osteoporosis is focused on the 
spine and hip fractures. However, there are insufficient 
data on the epidemiology and consequences of other 
osteoporotic fractures.
For 45-year-old people the lifetime risks of 
shoulder and forearm fractures are 13.3 % and 21.5 % 
in women and 4.4 % and 5.2 % in men, respectively 
(3). Ten-year and 15-year risks for all fractures increase 
until the age of 80. After that, due to the competitive 
risk of fracture and death, they approach the lifetime 
risk of fracture. Peripheral non-hip fractures account 
for 90 % of all fractures until the age of 80 and for 
59 % after that age (4).
Data from placebo groups included in large 
phase III clinical trials are very useful in analysing 
the incidence of peripheral fractures. The incidences 
range between 4.9 % and 12 %, and more often refer 
to all peripheral fractures, rather than for specific 
sites (5-8).
In a large population-based three-year study in 
England, the annual fracture incidence was 19 per 
100,000 people for metacarpal bones and 243 per 
100,000 for distal forearm, with significant differences 
in men-to-women ratios between metacarpal bones 
(0.16) and distal radius (1.33) (Table 1) (9). Until the 
age of 55 years, fractures were more often in men and 
after that age in women (9). 
Similar data were found in a ten-year trial in 
England and Wales (10). The most frequent fracture 
sites were distal radius in women (30.2 per 10,000 
54
a year) and carpal bones in men (26.2 per 10,000 a 
year). Fractures of carpal bones, feet, tibia and fibula 
are more frequent in childhood and in young people, 
while fractures of the spine, distal radius, hip, proximal 
humerus, ribs, clavicle and pelvis are more frequent in 
the older age, although the clavicle has two incidence 
peaks (11).
There are significant demographic differences in 
the incidence of fractures in general, as well as of the 
fracture of distal radius, which is a typical peripheral 
fracture. The range of incidences is wide and reflects 
racial differences. For example, in Nigeria, the 
incidence of fractures is 3 per 100,000 women and 4 
per 100,000 men, while the incidence in Norway is 767 
per 100,000 women and 202 per 100,000 men (11). 
Similar to spine and hip fractures, an increase in the 
incidence of osteoporotic fractures of other sites has 
been noticed over the past decades, which has been 
evidenced for proximal humerus fractures (12, 13).
Data from epidemiological studies for non-hip 
non-vertebral osteoporotic fractures in Croatia are 
lacking. The Croatian Health Service Yearbook is 
an up-to date source where data are gathered from 
hospital discharge documentation. Among fifteen 
leading injuries in hospitalised patients aged 60 years 
and above in 2006, fractures of the lower leg, including 
the ankle, accounted for 11.5 %, and together with 
other peripheral non-hip fractures for 23.7 % of all 
injuries (14).
Risk factors
It seems that non-hip peripheral fractures are 
related to low bone mineral density (BMD) and to 
other standard risk factors, especially to age. A study 
of Becker et al. (15) showed a significant heterogeneity 
in risk factors for falls and osteoporosis in old people 
hospitalised due to osteoporotic fractures. Those 
differences included sex, ethnicity and the type of 
fracture, but not BMD, which was low in all patients, 
save for the total hip region. Ten-year probability 
of osteoporotic fractures increases with age and 
lower T-score, with the exception of fractures of 
distal radius in men (16). BMD value better predicts 
the incidence of proximal femur fracture then of 
peripheral and spinal fracture (17). Other studies 
showed several independent risk factors for different 
fractures: low hip BMD in both sexes and low body 
weight in women for humerus fracture; low hip BMD, 
low body height, and history of falls in women (and
low calcium intake in men for radius fracture (18). 
The Epidemiology of Osteoporosis Study (EPIDOS), 
which included 7,598 French women aged over 
74 years, showed the importance of low BMD and 
falls for proximal humerus fractures in women (19). 
However, the National Study for Osteoporosis Risk 
Assessment (NORA), which was based on a cohort 
of approximately 150,000 postmenopausal Caucasian 
women in the USA, found that as many as 82 % of 
women with peripheral fracture had T-score better 
than -2.5 (20). The same study showed for the first 
time, that fracture risk in younger postmenopausal 
women (aged 50 to 64 years) with low BMD was similar 
to the risk in women aged 65 or over. In a prospective, 
population-based, cohort Rotterdam Study, which 
investigated factors that determine the occurrence of 
many chronic diseases in elderly people, only 44 % of 
all non-vertebral fractures in women and 21 % of all 
non-vertebral fractures in men occurred at T-scores 
lower than -2.5 (21). Gallagher et al. noticed that 
vitamin D deficiency in older people with osteoporotic 
fractures had greater influence on hip fracture than 
on other fractures (22).
Studies in peri- and postmenopausal women 
showed that the risk of new fracture was twice as great 
in women with previous fracture as in women who had 
Table 1 Annual incidence of non-hip peripheral fractures (adapted from reference 9)*
Incidence per 100,000
Fracture site Men (M) Women (W) Ratio W/M
Distal radius and ulna 182 243 1.33
Ankle 87 65 0.75
Humerus 58 76 1.31
Clavicle 67 32 0.47
Metacarpal bones 117 19 0.16
Tarsal and metatarsal bones 73 52 0.71
*Leicestershire (UK) – N=23,276 (12,771 men and 10,566 women); fractures in 3 years.
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no fracture (23). The results of Multiple Outcomes 
of Raloxifene Evaluation (MORE) study in placebo 
controls showed that severity was a better predictor 
of new non-vertebral fractures than the number of 
previous fractures (24). Previous fractures of distal 
forearm can also be a predictor of new osteoporotic 
fractures. Overall ten-year cumulative incidence for 
any fracture was 55 %: for the hip fracture if the distal 
forearm fracture has occurred after 70 years of life, 
and for the spinal fracture independently of the age 
of occurrence (25). This was confirmed in by recently 
published data from the NORA study. Prior wrist 
fracture was a good predictor of the three-year risk of 
any future osteoporotic fracture in older and younger 
postmenopausal women, independent of the baseline 
BMD and common osteoporosis risk factors (26). Rib 
fractures can also predict future, mainly humerus and 
hip fractures in women (27).
For non-hip and non-vertebral fractures in Croatia 
the only relevant study is the one by Matkovi} et al., 
who evaluated bone status and fracture rates in two 
populations with very different dietary habits. Although 
there was a higher rate of proximal femur fracture in 
the district with lower calcium intake, no difference 
was found for the forearm fracture rates between the 
two regions (28).
Mortality, health-related quality of life, and 
economic burden
Johnell et al. (29) explored epidemiological 
characteristics of mortality after fractures. In a sample 
of nearly 3,000 inhabitants of Malmö (Sweden), they 
found the highest mortality in the first year after 
fracture, and it was greater in men than in women. 
The one-year survival after fracture was higher for 
forearm and shoulder fractures (94 % and 87 %, 
respectively) than for spine and hip fractures (72 % 
and 78 %, respectively). Similar was found five years 
later, when the survival rate for forearm fracture was 
74 %, for shoulder fracture 64 %, for hip fracture 41 %, 
and for spine fracture 28 %. A significant increase in 
mortality risk after clinical osteoporotic fractures was 
found in the Fracture Intervention Trial (FIT) study, a 
randomized, placebo-controlled trial designed to test 
the hypothesis that alendronate reduced the rate of 
fractures in 6,457 women aged 55 to 80 years with low 
hip BMD (30). The overall age-adjusted relative risk of 
death following a clinical fracture was 2.15 (95 % CI = 
1.36 to 3.42). The greatest risk was shown for spine 
fracture (8.64 times) and hip fracture (6.68 times), 
while it did not increase for forearm fracture. Results 
were similar after adjusting for assigned treatment, 
health status and specific common co-morbidities.
Osteoporotic fractures are associated with 
increased direct and indirect costs. According to 
the US data, the highest costs in the first year are 
associated with the fracture of distal and proximal 
femur (median US$ 11,756 and 11,241, respectively), 
and then with the lower leg fracture (US$ 2,967), 
while the lowest costs are associated with rib fracture 
(US$ 213) (31). Although there is a linear relationship 
between cost and post-fracture disability, relative 
costs associated with humerus fracture are somewhat 
higher (US$ 2.317) than the relative disability cost 
that ensued. According to the National Committee of 
Health, costs associated with non-vertebral fractures in 
Sweden range between Euro 1,955 for hand fractures 
and Euro 3,745 for leg fractures, ankle included (32). 
The number of visits and time in the hospital also 
depend on the site of fracture. The average number 
of hospital admissions is lower for distal forearm 
fractures than for spine, shoulder and especially for 
hip fractures (33). Patients with hip and shoulder 
fractures most often visit the physiotherapist, and 
patients with spine and forearm fractures most often 
visit the hospital and family physicians. In the Unites 
States, medical costs of non-hip fractures are huge, 
accounting for no less than 36.9 % of all national 
medical costs (34).
Regulatory changes in Europe
The importance of non-hip peripheral fractures 
has been acknowledged through amendments to the 
“Guideline on the evaluation of medicinal products 
in the treatment of primary osteoporosis” (35). 
Until recently, the EU Guideline was  focused on hip 
fractures, among non-vertebral fractures. Now, to 
confirm drug anti-fracture efficacy, it is necessary 
to study parameters for both vertebral (clinical and 
morphometric) and all non-vertebral fractures, 
including the hip (35).
To conclude, peripheral non-hip fractures are 
frequent and easy to diagnose. They are neglected 
and less studied than fractures at other sites. 
Although no increased mortality risk is associated with 
peripheral fractures except for the hip and radiocarpal 
joint, they considerably affect the quality of life and 
burden economy. Fractures caused by low-energy 
trauma, save for the fractures of the skull, cervical 
spine, arm and foot fingers, require further testing 
for osteoporosis, especially in people older than 50 
years.
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Sa`etak
PERIFERNE OSTEOPOROTSKE FRAKTURE OSIM KUKA - EPIDEMIOLOGIJA I ZNA^ENJE
Prijelomi su najozbiljnija posljedica osteoporoze. Iako ~ine ve}inu svih fraktura, nevertebralne frakture 
osim kuka rijetko se prepoznaju kao zna~ajne. Naj~e{}e lokalizacije tih prijeloma su: distalni dio radijusa, 
proksimalni dio humerusa, rebra, klavikula i zdjelica. Prema rezultatima iz placebo-grupa III. faze velikih 
klini~kih ispitivanja raspon njihove incidencije iznosi izme|u 4,9 % i 12,0 %. Prema podacima bolni~kog 
pobolijevanja za 2006. g. u Hrvatskoj, me|u 15 vode}ih ozljeda u dobnoj grupi 60 i vi{e godina 23,7 % 
bile su periferne frakture osim kuka. ^imbenici rizika za nevertebralne frakture osim onih kuka sli~ni 
su kao i za druge osteoporotske frakture gdje sredi{nje mjesto imaju niska mineralna gusto}a kosti i 
prethodne frakture. Ove frakture imaju velik utjecaj na kvalitetu `ivota, a njihovi su tro{kovi vrlo visoki, 
tako da u SAD-u iznose ~ak 36.9 % svih nacionalnih medicinskih tro{kova. Nevertebralne frakture osim 
kuka zahtijevaju ve}u pozornost, {to su i prepoznala europska regulatorna tijela koja odobravaju upotrebu 
antiosteoporotskih lijekova.
KLJU^NE RIJE^I: kvaliteta `ivota, mineralna gusto}a kosti, nevertebralne frakture, osteoporoza, 
tro{kovi lije~enja
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